Peptide

Oxytocin

FDA-approved product exists
6.5/10

BioHarmony verdict

Worth trying

Intranasal oxytocin is the endogenous bonding hormone used off-label as a nasal spray for social connection, anxiety, and libido. It is exceptionally safe, with no reliable side effects across 38 trials per MacDonald 2011, but the marketed brain effects are inconsistent: the largest autism RCT in 290 children was null per Sikich 2021.

Read full report

What is Oxytocin?

Intranasal oxytocin is your body's own bonding and trust hormone, oxytocin, delivered as a nasal spray and used off-label for social connection, anxiety, mood, and libido. It is one of the safest things in the peptide world and rests on one of the largest research bases in social neuroscience, yet the effects it is actually marketed for are inconsistent. The honest one-line version: real but oversold, and very safe to try. The most-cited number that built its reputation, a "trust" boost, has not replicated well, per Nave 2015, while the largest and best-run therapeutic trial, in 290 children, found no benefit at all, per Sikich 2021.

From the BioHarmony report, reviewed 2026-09-08.

How it is thought to work

Agonist at the oxytocin receptor in limbic and social-salience brain regions

Safety watch-outs

  • Emotional blunting, flatness, or irritability that builds with repeated dosing: stop and reassess, since chronic use raises an unproven…
  • A fading effect over weeks of daily use: a sign to cycle off rather than escalate the dose.
  • Any nasal irritation, persistent headache, or other reaction that does not settle: stop and check your source quality.
  • Using it to force connection in a relationship that feels off: a behavioral red flag, not a pharmacological one, since oxytocin tunes…

Full risk profile in the BioHarmony report.

Dosing as published

Approved labelPITOCIN prescribing information for induction or stimulation of labor in a monitored obstetric setting
PopulationObstetric patients for whom the labeled indication applies
DoseBegin intravenous infusion at 0.5-1 milliunit/minute and increase by 1-2 milliunits/minute at 30-60 minute intervals until the desired contraction pattern is established; the label provides separate regimens for postpartum bleeding and abortion-related indications.
RouteIntravenous infusion by infusion pump for labor induction or stimulation
FrequencyContinuous, titrated infusion with uterine and fetal monitoring
DurationProcedure-specific use in a monitored clinical setting
PreparationFor the standard labor-induction infusion, add one 1 mL vial containing 10 units to 1,000 mL of 0.9% sodium chloride or Ringer's lactate, producing 10 milliunits/mL, then rotate the container to mix thoroughly.
Source: Dosage and Administration, Induction or Stimulation of Labor

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Educator coverage (2)

Attributed viewpoints, separate from primary research.

Trust & sourcing

US approvalFDA-approved product exists
CompoundingApproved injectable products exist; promoted appetite or fat-loss uses are not established by the approval
Last checked2026-07-13
Next review2026-10-11

FDA-approved synthetic oxytocin injection is marketed as Pitocin for specified obstetric uses. The reviewed label does not support appetite-control, fat-loss, or wellness protocols.

Primary sources

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.